|
Sudeshna RayThe Ken |
Hospitals and stockists are making steep margins off initiatives meant to make life-saving medication affordable
Reliance on pre-existing tech and a dearth of data dim Cent’s otherwise laudable goal of AI-aided early detection
As Novo prepares to lose market exclusivity in India, it sets its sights on the healthcare system, partnering with Healthifyme, buying hospitals, and...